Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Drug-induced cutaneous vasculitis in patients with non-Hodgkin's lymphoma receiving bortezomib: A possible surrogate marker of response
    Meeting Abstract

    Gerecitano, J.; Goy, A.; Macgregor-Cortelli, B.; Neylon, E.; Wright, J.; Esseltine, D.; Schenkein, D.; Gonen, M.; O'Connor, O. A.
    Blood (2005)

    Fulltext@MSK | Save
  • The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
    Journal Article

    She, Qing Bai; Solit, David B.; Ye, Qing; O'reilly, Kathryn E; Lobo, Jose; Rosen, Neal
    Cancer Cell (2005)

    Fulltext@MSK | Save
  • The role of fluoro-deoxy glucose (FDG) positron emission tomography (PET) in the management of differentiated thyroid cancer
    Book Section

    Robbins, R. J.; Chan, C. Y.; Tuttle, R. M.; Larson, S. M.
    In Haugen, B. (Eds.) Thyroid Neoplasms (2005)

    Fulltext@MSK | Save
  • Memory
    Book Section

    Ploss, A.; Pamer, E. G.
    In Kaufmann, S. H. E. (Eds.) Novel Vaccination Strategies (2004)

    Fulltext@MSK | Save
  • Confocal theta line-scanner for imaging skin: A comparison to the point scanner
    Conference Paper

    Rajadhyaksha, M.; Dwyer, P. J.; DiMarzio, C. A.; Fox, W. J.; Zavislan, J. M.
    Optica Publishing Group (formerly Osa) (2004)

    Fulltext@MSK | Save
  • Confocal reflectance theta line-scanner for imaging human skin in vivo
    Conference Paper

    Dwyer, P. J.; DiMarzio, C. A.; Rajadhyaksha, M.; Fox, W. J.; Zavislan, J. M.
    Optica Publishing Group (formerly Osa) (2004)

    Fulltext@MSK | Save
  • Confocal reflectance microscopy-guided margin-mapping of melanomas for pre-surgical planning
    Conference Paper

    Elias, M. D.; Rajadhyaksha, M.; Busam, K. J.; Halpern, A. C.; Marghoob, A.
    Optica Publishing Group (formerly Osa) (2004)

    Fulltext@MSK | Save
  • Alternative and complimentary treatments
    Book Section

    Cassileth, B. R.
    In Clavien, P. A.; Fong, Y.; Lyerly, H. K.; Morse, M. A.; Venook, A. P. (Eds.) Malignant Liver Tumors: Current and Emerging Therapies. 2nd ed (2004)

    Fulltext@MSK | Save
  • Novel therapies targeted at signal transduction in liver tumors
    Book Section

    Abou-Alfa, G. K.; Morse, M. A.
    In Clavien, P. A.; Fong, Y.; Lyerly, H. K.; Morse, M. A.; Venook, A. P. (Eds.) Malignant Liver Tumors: Current and Emerging Therapies. 2nd ed (2004)

    Fulltext@MSK | Save
  • Prospective evaluation of the utility of the serum free light chain assay (FLC), clonal Ig V(L) gene identification and troponin I levels in a phase II trial of risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis
    Conference Paper

    Comenzo, R. L.; Zhou, P.; Reich, L.; Costello, S.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    CRC Press (2004)

    Fulltext@MSK | Save